Interview Released with Novartis ahead of Pre-Filled Syringes & Injectable Drug Devices Europe 2019 Read more
Octapharma receives Swissmedic approval for fibryga to treat congenital and acquired fibrinogen deficiencies Read more
CBT and Zhejiang Bossan Enter into a Collaboration and License Agreement to Develop Combination Cancer Treatments Read more
Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company Read more
Fusion Antibodies and Analytics Engines to Incorporate Artificial Intelligence into Its World Class Antibody Humanization Service Read more
Machavert Pharmaceuticals Unveils a New Bioactive Lipid Drug Candidate for Cancer Treatment Read more